India will resume exporting COVID-19 vaccines from October, five months after it halted sending supplies overseas as it battled a deadly wave of infections, the health minister said Monday.
The South Asian giant, dubbed the “pharmacy of the world,” was a major supplier to the Covax program aimed at boosting immunization in poorer nations.
Exports stopped in April, according to foreign ministry data, when a virus surge in India pushed the healthcare system to breaking point and there was a huge demand for jabs.
Health Minister Mansukh Mandaviya said more than 300 million vaccine doses would be produced in October and one billion in the last three months of the year.
“India will be resuming export of vaccines... in order to fulfill the commitment of India towards Covax,” Mandaviya said in a statement.
“The surplus supply of vaccines will be used to fulfill our commitment towards the world for the collective fight against COVID-19.”
Launched in January, India’s vaccination campaign was slow to take off because of shortages and hesitancy among the population.
But the pace has picked up in recent weeks, with authorities currently administering between five to eight million coronavirus shots every day.
The country hit a record 22 million coronavirus jabs in a day on Friday as part of a special vaccination drive for the birthday of Prime Minister Narendra Modi.
Plans for African COVID-19 vaccine production hubs could be ‘revolutionary’Plans for Africa’s first independent COVID-19 vaccine production hubs could revolutionize the global vaccine industry but will depend on the ... Coronavirus
Egypt ramps up local COVID-19 vaccine production with eye on exportsEgypt is ramping up production of the Sinovac coronavirus vaccine as it aims to become a hub for vaccine exports to Africa and protect its own ... Coronavirus
Moderna to start local production of COVID-19 mRNA vaccine in CanadaModerna Inc said on Tuesday it had agreed with the Canadian government to start domestic production of mRNA vaccines as the country looks to boost ... Coronavirus
Drugmaker Sanofi to invest $475million in new Singapore vaccine production siteFrench drugmaker Sanofi said on Monday it would invest 400 million euros ($475.40 million) over five years in a new vaccine production site in ... Coronavirus